-
印尼医疗器械报告 - 2018年第二季度
Tenth largest market in the Asia Pacific (APAC) region. Fourth lowest per capita spending in the APAC region. The market will grow by a high CAGR.
• Other medical devices and diagnostic imaging have the largest market shares. The market remains heavily reliant on imports. Domestic production focuses mainly on the manufacture of basic items. Demand is centred in the capital, Jakarta and surrounding areas in Java, where the bulk of the country's best facilities will be
found.
-
爱尔兰医疗器械报告 - 2018年第二季度
Amongst the 40 largest medical device markets in the world. Among the top 20 in terms of per capita spending, although the level is below the regional average. Market 60% reliant upon imports.
• Relatively high market growth supported by economic outperformance in Western Europe. Market is predominantly centred in Dublin and Cork, which account for one third of the population. Market is dominated by the public sector with a small private hospital sector largely restricted to religious charitable foundations. Major producer of medical devices due to the presence of US multinationals, which have relocated to take advantage of lower
manufacturing costs. Fourth largest exporter of medical devices within the EU. Substantial re-export activity.
-
哥伦比亚医疗器械报告-2018年第二季度
Colombia is the third largest market in Latin America. The market represents around 5% of health expenditure. Other medical devices and consumables have the largest market shares. The market relies on imports, despite strong domestic production focused on consumables. The market will record high growth. Per capita expenditure is low, therefore there is considerable growth potential.
-
卡塔尔医疗器械报告 - 2018年第二季度
Small but sophisticated medical device market. Imports supply most of the market. Other medical devices and diagnostic imaging have the largest market shares. High per capita spending in the Middle East Africa region. High single-digit market CAGR driven by the National Health Strategy.
-
巴基斯坦医疗器械报告-2018年第二季度
Second smallest market in the Asia Pacific (APAC) region. Per capita spending is one of the lowest in the world. Market growth will be below average for the region. Other medical devices and consumables have the largest market shares. The market is heavily reliant on imports. Domestic manufacturing is concentrated in Sialkot and centres mainly around steel surgical instruments and other hand held
medical devices. Production is of a high quality but mostly destined for export.
-
俄罗斯医疗器械报告 - 2018年第二季度
Largest medical device market in the Central & Eastern Europe (CEE) region. Per capita spending is low for the CEE region.Market will record moderate growth in US dollar terms. Other medical devices and diagnostic imaging have the largest market shares. The government has increased the number of medical devices subject to import restrictions, which could negatively impact the
sales of foreign manufacturers. Import shares may fall by 2020, in accordance with the Ministry of Industry and Trade's import substitution plan, which aims to
reduce the import shares of 111 groups of medical devices. The greatest opportunities exist around the major cities of Moscow and St Petersburg, where most companies are based and per
capita incomes are well above the national average.
-
罗马尼亚医药与保健报告 - 2018年第二季度
Romania is one of the largest pharmaceutical markets in the Central and Eastern European region. However, its low per capita
medicine expenditure reflects its relative lack of development compared to its more prominent Central European peers such as
Poland, Czech Republic and Hungary. As such, growth opportunities are significant.
-
尼日利亚医疗器械报告 - 2018年第二季度
Fourth smallest market in the Middle East and Africa (MENA) region. Per capita spending of less than USD1 is the lowest in the MENA region. Moderate US dollar 2017-2022 CAGR, higher growth in local currency terms due to naira weakness Consumables is the largest product area. The orthopaedics & prosthetics market is particularly under-developed. Most requirements need to be imported as domestic production is negligible. Despite efforts to achieve universal health coverage and raise investment levels, the health sector is massively underfunded.
-
欧洲和中国营养和膳食补充剂市场分析
We have estimated the China nutrition and dietary supplements market by segmenting it into
four levels: functions, formulations, age category, and region. On the basis of functions, the
market is segmented into medical foods, sports nutrition, dietary supplements, and functional
foods. Furthermore, dietary supplements are categorized into vitamins, minerals, enzymes,
amino acids, and others. By formulations the market is segmented into tablet, capsules, powder,
liquid, soft gel, and gel caps. On the basis of age category, the market is segmented into infant,
children, adult, pregnant, and geriatric.
-
摩洛哥医疗器械报告 - 2018年第二季度
Small, underfunded market. Per capita medical device spending is below average for the MEA region. Market growth well above the global average forecast. Public hospital network is likely to be major purchaser due to out of date equipment. Universal health insurance system being implemented. Private sector set for a period of renewed growth as a result of moves to open up private clinics to commercial investors. Imports supply over 90% of the market. Capital investment projects rely on finance from sources outside Morocco. Training medical staff being prioritised.
-
伊拉克医疗器械报告 - 2018年第二季度
Largely poor population but rising health expenditure. Healthcare infrastructure in need of an overhaul. Private sector under-developed.
• Sizeable medical device market in the Middle East and Africa region. Medical device market growth hindered by political instability and low oil prices. Medical device market heavily reliant on imports. Very little medical device production. Low per capita medical device expenditure.
-
古巴医疗器械报告 - 2018年第2季度
Highly centralised healthcare sector, controlled by the government. Smallest medical device market in the Americas region. Other medical devices, consumables and diagnostic imaging have the highest market shares. Market heavily reliant on medical device imports, particularly from Europe, China and Japan. Lack of advanced medical device manufacturing capacity. Moderate medical device market growth over the forecast period. One of the smallest per capita medical device expenditures in the region.
-
立陶宛制药与医疗保健报告 - 2018年第二季度
-
沙特阿拉伯医疗器械报告 - 2018年第二季度
Oil wealth has facilitated development of sophisticated healthcare system. The largest medical device market in the Middle East and Africa region. Market size reduced and market forecast revised upwards in December 2017. Reliant on imports, primarily from the US and Western Europe. Other medical devices and consumables have large market shares. improving regulations, which are approaching standards seen in developed states. Limited direct presence of multinational companies.
-
罗马尼亚医疗器械报告-2018年第二季度
Eighth largest Central & Eastern European (CEE) market. Per capita spending is below the CEE average. The market will grow by a high US dollar CAGR.
• Other medical devices and diagnostic imaging have the largest market shares. There is little local production, so much of the market is largely reliant on imports. The health sector is historically underdeveloped, poorly funded and poorly managed. Growing private healthcare sector. Continued World Bank support should maintain progress in developing the health sector. One of the CEE region's most populous countries.
-
捷克共和国医疗器械报告 - 2018年第2季度
Fourth largest market in the CEE region. Per capita spending is well above the CEE average. Market will record a moderate CAGR. Consumables and other medical devices have the largest market shares. Much of the market is still largely reliant on imports.
• Growing domestic production sector, aided by foreign investment. Well-established public health system, funded by compulsory insurance. The private sector is gradually expanding.
-
巴西医疗器械报告 - 2018年第二季度
Private sector accounts for more than 60% of hospital beds. Largest market in Latin America and ranked among the top-15 markets globally. Above average per capita spending in Latin America but with wide regional variations. Consumables account for the largest market share at more than a quarter of the total market. Moderate market growth in local currency terms from 2018 as the economy regains momentum. Lower market growth in US dollar terms as the real enters another depreciatory trend. Well established local and multinational industry geared to the domestic market. High-tech market is reliant on imports, although local production is growing. Increasing consumer demand for the latest medical technology.
-
肯尼亚医疗器械报告 - 2018年第二季度
Fourth smallest market in the MENA region. Per capita spending is well below the MENA average. Other medical devices and diagnostic imaging have the largest market shares. Most requirements need to be imported as the small domestic production sector concentrates on low-cost items. COMESA and EAC membership has boosted regional trade; 75% of exports are shipped to other African countries. Capital injections from multinationals have made Kenya a hub for medical technologies and innovations. Health system reform is aided by international funding.
-
黎巴嫩医疗器械报告 - 2018年第二季度
Small market in the Middle East and Africa region; it ranks outside the top-10.
• Average per capita expenditure in the region.
• Moderate market growth.
• After other medical devices, diagnostic imaging has the largest market share.
• Market heavily reliant on imports, particularly from Europe, the US and China.
• Positive demographic drivers, including ageing population and increasing chronic diseases.
• Healthcare infrastructure developments will also encourage market growth.
-
匈牙利医疗器械报告 - 2018年第二季度
Fifth largest market in the CEE region. Sixth highest per capita spending in the CEE region. Market will record a high single-digit CAGR in US dollar terms. Consumables and diagnostic imaging have the largest market shares. Most of the market is reliant on imports. Longstanding tradition of manufacturing and exporting in fields such as diagnostic imaging. Hungary has a comprehensive if outdated public hospital sector, and a growing private sector.